Baidu
map

Braz J Psychiatry:舌下含服和口服唑吡坦可有效治疗失眠症

2020-10-05 MedSci原创 MedSci原创

本研究旨在评估5毫克舌下含服剂量的唑吡坦与10毫克口服剂量相比,在睡前和半夜醒来后 "按需 "服用的安全性和有效性,研究结果已在线发表于Braz J Psychiatry。

本研究旨在评估5毫克舌下含服剂量的唑吡坦与10毫克口服剂量相比,在睡前和半夜醒来后 "按需 "服用的安全性和有效性,研究结果已在线发表于Braz J Psychiatry。

参与者被随机分为口服组(口服唑吡坦10毫克和舌下安慰剂在睡前和 "按需")和舌下组(口服安慰剂和舌下唑吡坦5毫克在睡前和 "按需")。参与者接受了医学评估、多导睡眠图、精神运动警觉性测试,并填写了问卷。

 

85名患者中,67名符合失眠标准(48±10岁;79%为女性),并被随机分组。其中,46人完成92±5天的治疗。25%的参与者报告了轻度到中度的不良事件,包括头痛、困倦和头晕。两种治疗均使半夜觉醒天数平均减少-3.1±2.3天/周,总睡眠时间增加1.5小时。睡眠质量和失眠严重程度评分的变化也得到改善,组间具有可比性:差异取决于继续治疗的情况。关于PSG结果,舌下组的睡眠潜伏期比口服组减少更多(-14±42 vs. 10±29分钟;P = 0.03)。心理运动警觉性测试在觉醒后30分钟出现轻微的残留效应,2小时后恢复。

综上所述,该研究结果表明,两种唑吡坦制剂的安全性和有效性相当。舌下含服5mg剂量诱导睡眠更迅速。

 

原始出处:

 

Laura S CastroLeonardo J Otuyama, et al., Sublingual and oral zolpidem for insomnia disorder: a 3-month randomized trial. Braz J Psychiatry. 2020 Apr;42(2):175-184. doi: 10.1590/1516-4446-2019-0389. 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1792193, encodeId=25371e9219383, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sun Jul 04 06:31:55 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951451, encodeId=e19295145145, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=464e4070825, createdName=898319336, createdTime=Fri Mar 26 20:16:34 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1714894, encodeId=db3b1e14894fa, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3073, encryptionId=021230e312, topicName=AZ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e5031899089, createdName=12498e5fm22(暂无昵称), createdTime=Tue Apr 20 02:31:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890458, encodeId=620689045879, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Wed Oct 07 07:17:56 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299391, encodeId=ad121299391fc, content=<a href='/topic/show?id=59d64429252' target=_blank style='color:#2F92EE;'>#失眠症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44292, encryptionId=59d64429252, topicName=失眠症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509224, encodeId=8a901509224af, content=<a href='/topic/show?id=bbbc400101f' target=_blank style='color:#2F92EE;'>#唑吡坦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40010, encryptionId=bbbc400101f, topicName=唑吡坦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1fb10082206, createdName=周虎, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584986, encodeId=ec98158498634, content=<a href='/topic/show?id=4d9a8654388' target=_blank style='color:#2F92EE;'>#舌下含服#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86543, encryptionId=4d9a8654388, topicName=舌下含服)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5217091033, createdName=循证小兵, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619571, encodeId=765e16195e111, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1792193, encodeId=25371e9219383, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sun Jul 04 06:31:55 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951451, encodeId=e19295145145, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=464e4070825, createdName=898319336, createdTime=Fri Mar 26 20:16:34 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1714894, encodeId=db3b1e14894fa, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3073, encryptionId=021230e312, topicName=AZ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e5031899089, createdName=12498e5fm22(暂无昵称), createdTime=Tue Apr 20 02:31:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890458, encodeId=620689045879, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Wed Oct 07 07:17:56 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299391, encodeId=ad121299391fc, content=<a href='/topic/show?id=59d64429252' target=_blank style='color:#2F92EE;'>#失眠症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44292, encryptionId=59d64429252, topicName=失眠症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509224, encodeId=8a901509224af, content=<a href='/topic/show?id=bbbc400101f' target=_blank style='color:#2F92EE;'>#唑吡坦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40010, encryptionId=bbbc400101f, topicName=唑吡坦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1fb10082206, createdName=周虎, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584986, encodeId=ec98158498634, content=<a href='/topic/show?id=4d9a8654388' target=_blank style='color:#2F92EE;'>#舌下含服#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86543, encryptionId=4d9a8654388, topicName=舌下含服)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5217091033, createdName=循证小兵, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619571, encodeId=765e16195e111, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
    2021-03-26 898319336

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1792193, encodeId=25371e9219383, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sun Jul 04 06:31:55 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951451, encodeId=e19295145145, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=464e4070825, createdName=898319336, createdTime=Fri Mar 26 20:16:34 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1714894, encodeId=db3b1e14894fa, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3073, encryptionId=021230e312, topicName=AZ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e5031899089, createdName=12498e5fm22(暂无昵称), createdTime=Tue Apr 20 02:31:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890458, encodeId=620689045879, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Wed Oct 07 07:17:56 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299391, encodeId=ad121299391fc, content=<a href='/topic/show?id=59d64429252' target=_blank style='color:#2F92EE;'>#失眠症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44292, encryptionId=59d64429252, topicName=失眠症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509224, encodeId=8a901509224af, content=<a href='/topic/show?id=bbbc400101f' target=_blank style='color:#2F92EE;'>#唑吡坦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40010, encryptionId=bbbc400101f, topicName=唑吡坦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1fb10082206, createdName=周虎, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584986, encodeId=ec98158498634, content=<a href='/topic/show?id=4d9a8654388' target=_blank style='color:#2F92EE;'>#舌下含服#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86543, encryptionId=4d9a8654388, topicName=舌下含服)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5217091033, createdName=循证小兵, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619571, encodeId=765e16195e111, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1792193, encodeId=25371e9219383, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sun Jul 04 06:31:55 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951451, encodeId=e19295145145, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=464e4070825, createdName=898319336, createdTime=Fri Mar 26 20:16:34 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1714894, encodeId=db3b1e14894fa, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3073, encryptionId=021230e312, topicName=AZ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e5031899089, createdName=12498e5fm22(暂无昵称), createdTime=Tue Apr 20 02:31:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890458, encodeId=620689045879, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Wed Oct 07 07:17:56 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299391, encodeId=ad121299391fc, content=<a href='/topic/show?id=59d64429252' target=_blank style='color:#2F92EE;'>#失眠症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44292, encryptionId=59d64429252, topicName=失眠症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509224, encodeId=8a901509224af, content=<a href='/topic/show?id=bbbc400101f' target=_blank style='color:#2F92EE;'>#唑吡坦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40010, encryptionId=bbbc400101f, topicName=唑吡坦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1fb10082206, createdName=周虎, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584986, encodeId=ec98158498634, content=<a href='/topic/show?id=4d9a8654388' target=_blank style='color:#2F92EE;'>#舌下含服#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86543, encryptionId=4d9a8654388, topicName=舌下含服)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5217091033, createdName=循证小兵, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619571, encodeId=765e16195e111, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
    2020-10-07 刘煜

    阅读谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1792193, encodeId=25371e9219383, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sun Jul 04 06:31:55 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951451, encodeId=e19295145145, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=464e4070825, createdName=898319336, createdTime=Fri Mar 26 20:16:34 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1714894, encodeId=db3b1e14894fa, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3073, encryptionId=021230e312, topicName=AZ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e5031899089, createdName=12498e5fm22(暂无昵称), createdTime=Tue Apr 20 02:31:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890458, encodeId=620689045879, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Wed Oct 07 07:17:56 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299391, encodeId=ad121299391fc, content=<a href='/topic/show?id=59d64429252' target=_blank style='color:#2F92EE;'>#失眠症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44292, encryptionId=59d64429252, topicName=失眠症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509224, encodeId=8a901509224af, content=<a href='/topic/show?id=bbbc400101f' target=_blank style='color:#2F92EE;'>#唑吡坦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40010, encryptionId=bbbc400101f, topicName=唑吡坦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1fb10082206, createdName=周虎, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584986, encodeId=ec98158498634, content=<a href='/topic/show?id=4d9a8654388' target=_blank style='color:#2F92EE;'>#舌下含服#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86543, encryptionId=4d9a8654388, topicName=舌下含服)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5217091033, createdName=循证小兵, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619571, encodeId=765e16195e111, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
    2020-10-06 日月
  6. [GetPortalCommentsPageByObjectIdResponse(id=1792193, encodeId=25371e9219383, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sun Jul 04 06:31:55 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951451, encodeId=e19295145145, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=464e4070825, createdName=898319336, createdTime=Fri Mar 26 20:16:34 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1714894, encodeId=db3b1e14894fa, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3073, encryptionId=021230e312, topicName=AZ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e5031899089, createdName=12498e5fm22(暂无昵称), createdTime=Tue Apr 20 02:31:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890458, encodeId=620689045879, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Wed Oct 07 07:17:56 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299391, encodeId=ad121299391fc, content=<a href='/topic/show?id=59d64429252' target=_blank style='color:#2F92EE;'>#失眠症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44292, encryptionId=59d64429252, topicName=失眠症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509224, encodeId=8a901509224af, content=<a href='/topic/show?id=bbbc400101f' target=_blank style='color:#2F92EE;'>#唑吡坦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40010, encryptionId=bbbc400101f, topicName=唑吡坦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1fb10082206, createdName=周虎, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584986, encodeId=ec98158498634, content=<a href='/topic/show?id=4d9a8654388' target=_blank style='color:#2F92EE;'>#舌下含服#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86543, encryptionId=4d9a8654388, topicName=舌下含服)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5217091033, createdName=循证小兵, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619571, encodeId=765e16195e111, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
    2020-10-06 周虎
  7. [GetPortalCommentsPageByObjectIdResponse(id=1792193, encodeId=25371e9219383, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sun Jul 04 06:31:55 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951451, encodeId=e19295145145, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=464e4070825, createdName=898319336, createdTime=Fri Mar 26 20:16:34 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1714894, encodeId=db3b1e14894fa, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3073, encryptionId=021230e312, topicName=AZ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e5031899089, createdName=12498e5fm22(暂无昵称), createdTime=Tue Apr 20 02:31:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890458, encodeId=620689045879, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Wed Oct 07 07:17:56 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299391, encodeId=ad121299391fc, content=<a href='/topic/show?id=59d64429252' target=_blank style='color:#2F92EE;'>#失眠症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44292, encryptionId=59d64429252, topicName=失眠症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509224, encodeId=8a901509224af, content=<a href='/topic/show?id=bbbc400101f' target=_blank style='color:#2F92EE;'>#唑吡坦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40010, encryptionId=bbbc400101f, topicName=唑吡坦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1fb10082206, createdName=周虎, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584986, encodeId=ec98158498634, content=<a href='/topic/show?id=4d9a8654388' target=_blank style='color:#2F92EE;'>#舌下含服#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86543, encryptionId=4d9a8654388, topicName=舌下含服)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5217091033, createdName=循证小兵, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619571, encodeId=765e16195e111, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1792193, encodeId=25371e9219383, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Sun Jul 04 06:31:55 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951451, encodeId=e19295145145, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=464e4070825, createdName=898319336, createdTime=Fri Mar 26 20:16:34 CST 2021, time=2021-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1714894, encodeId=db3b1e14894fa, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3073, encryptionId=021230e312, topicName=AZ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e5031899089, createdName=12498e5fm22(暂无昵称), createdTime=Tue Apr 20 02:31:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890458, encodeId=620689045879, content=阅读谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2017/04/21/72142930668371951a41ef4ea4b233e6.jpg, createdBy=dcbc1715228, createdName=刘煜, createdTime=Wed Oct 07 07:17:56 CST 2020, time=2020-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1299391, encodeId=ad121299391fc, content=<a href='/topic/show?id=59d64429252' target=_blank style='color:#2F92EE;'>#失眠症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=140, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44292, encryptionId=59d64429252, topicName=失眠症)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a4d285, createdName=日月, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1509224, encodeId=8a901509224af, content=<a href='/topic/show?id=bbbc400101f' target=_blank style='color:#2F92EE;'>#唑吡坦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40010, encryptionId=bbbc400101f, topicName=唑吡坦)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1fb10082206, createdName=周虎, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1584986, encodeId=ec98158498634, content=<a href='/topic/show?id=4d9a8654388' target=_blank style='color:#2F92EE;'>#舌下含服#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86543, encryptionId=4d9a8654388, topicName=舌下含服)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5217091033, createdName=循证小兵, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619571, encodeId=765e16195e111, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Oct 06 17:31:55 CST 2020, time=2020-10-06, status=1, ipAttribution=)]

相关资讯

Diabetologia :研究确定新的2型糖尿病“风险因素大全”:失眠入选!

近日,发表在《Diabetologia(糖尿病学)》上的一项研究中,来自瑞典卡罗林斯卡研究所的科学家确定了新的2型糖尿病“风险因素大全”,并将失眠列为一个新风险因素。

SLEEP 2020:失眠患者的福音,Daridorexant的III期临床取得积极进展

结果表明,与安慰剂相比,Daridorexant显著改善了睡眠维持时间。

SLEEP 2020:DAYVIGO(lemborexant)治疗成年失眠,III期临床确认了其有效性和安全性

结果显示,在949例65岁及以上患者中有262例最早在第一周就报告sSOL降低。

Am J Resp Crit Care:睡眠呼吸障碍和失眠与高血压和糖尿病的关联

SDB与高血压和糖尿病有关。失眠与高血压有关。这些结果支持将睡眠障碍作为预防和减少疾病的可改变靶标的重要性。

The Lancet Digital Health:失眠新疗法可有效改善睡眠状况,降低睡眠药物依赖

一个奇怪的现象是,随着社会不断发展,睡不好、睡不着的人反而越来越多了。据统计,全球约有27%正在遭受失眠的折磨,而在中国,近3亿人存在睡眠障碍,并且每10位失眠人士中就有8人年龄在35岁以下。

Behav Sleep Med:认知行为疗法可改善心力衰竭患者的失眠状况

失眠在稳定型心力衰竭(HF)患者中很常见,并与炎症和自主神经功能改变有关。本研究旨在探究认知行为疗法治疗失眠(CBT-I)对下丘脑垂体(HPA)轴、自主神经功能、炎症和昼夜节律性的影响,以及这些生物标

Baidu
map
Baidu
map
Baidu
map